Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)

Market Cap	38.51B
Revenue (ttm)	2.33B
Net Income (ttm)	-1.05B
Shares Out	n/a
EPS (ttm)	-1.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,268,699
Average Volume	19,260,560
Open	41.20
Previous Close	41.00
Day's Range	40.01 - 41.20
52-Week Range	24.70 - 51.40
Beta	0.64
RSI	38.34
Earnings Date	Oct 28, 2025

About SHA:688180

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 2,578
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688180

Financial Performance

In 2024, SHA:688180's revenue was 1.95 billion, an increase of 29.67% compared to the previous year's 1.50 billion. Losses were -1.28 billion, -43.90% less than in 2023.